Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial

T.D. Latshang, Y. Nussbaumer-Ochsner, B. Kaufmann, S. Ulrich-Somaini, M. Kohler, R. Thurnheer, I. Fauchère, A.M. Saguner, F. Scherff, F. Duru, K.E. Bloch (Zurich, Muensterlingen-Scherzingen, Switzerland)

Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Session: Cardiovascular disease and sleep-disordered breathing
Session type: Oral Presentation
Number: 3291
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T.D. Latshang, Y. Nussbaumer-Ochsner, B. Kaufmann, S. Ulrich-Somaini, M. Kohler, R. Thurnheer, I. Fauchère, A.M. Saguner, F. Scherff, F. Duru, K.E. Bloch (Zurich, Muensterlingen-Scherzingen, Switzerland). Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial. Eur Respir J 2012; 40: Suppl. 56, 3291

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018
Year: 2018



CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017


CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Treatment of central and obstructive sleep apnea in stable heart failure patients with auto-servo ventilation reduces sleep fragmentation – A randomized controlled trial
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Source: Eur Respir J 2013; 42: 1244-1254
Year: 2013



Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003

Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Randomized trial of oropharyngeal exercises plus incentive spirometry on patients with mild to moderate obstructive sleep apnea syndrome
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018



Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Source: Eur Respir J, 52 (1) 1800149; 10.1183/13993003.00149-2018
Year: 2018



CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014



Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020



Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial
Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019
Year: 2020



The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021